<DOC>
	<DOC>NCT02747511</DOC>
	<brief_summary>Single center, double-blind, randomized, placebo-controlled trial evaluating analog pain scores in patients who present to the emergency department (ED) with a complaint of headache. A total of 150 patients age 13-55 presenting to the emergency department with headache will be enrolled from October 2015 - October 2016. Patients will be randomized and pain scores and side effects will be recorded at 0, 30, 60, and 90 minutes. Follow-up will be performed by telephone at 24 hours.</brief_summary>
	<brief_title>IV Haloperidol for the Treatment of Headache in the ED</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<criteria>Emergency Department patients that complain of headache or migraine Males and females age 1355 English is primary language Abnormal blood pressure (&gt;200/100) Sudden rapid onsent (normal to worst pain in minutes) Fever Trauma Any history of masses, strokes, head injury or other causes of abnormal anatomy QT greater than 450 ms on EKG Allergy to Haldon Any altered mental status (GCS &lt;15) Pregnancy Any abnormalities on neurologic exam Any clinician concern that would require CT scan of brain Any prisoner or ward of state</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>